BIGBEAR
PHARMACEUTICALS
Lusutrombopag is an oral thrombopoietin receptor agonist (TPO-RA) indicated for adult patients with chronic liver disease and thrombocytopenia who are scheduled to undergo surgery.
AuthenticGuaranteeFast DeliveryPrivacy Clinical Need for Thrombocytopenia TreatmentThrombocytopenia can result from many factors and is a common complication of chronic liver disease. Patie···【Read More】
Update: 05 Mar,2026Source: Haiou HealthViews: 71
FDA Approval AnnouncementOn July 31, 2018, the U.S. Food and Drug Administration approved lusutrombopag (Mulpleta, Shionogi Inc.) for the treatment of···【Read More】
Update: 05 Mar,2026Source: Haiou HealthViews: 70
Copyright2024@ BIGBEAR All right reserved BIGBEAR
